Boston Scientific Corporation (BSX) - Medical Equipment - Deals and Alliances Profile

Date: October 7, 2015
Pages: 246
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BE58B1BEEC3EN
Leaflet:

Download PDF Leaflet

Boston Scientific Corporation (BSX) - Medical Equipment - Deals and Alliances Profile
Summary

Boston Scientific Corporation (Boston Scientific) is a global medical device company. It carries out the development, manufacture and marketing of medical devices that are used in a range of interventional medical procedures. The company offers products in seven dedicated business groups, namely, Interventional Cardiology, Cardiac Rhythm Management (CRM), Peripheral Interventions, Electrophysiology, Endoscopy, Urology/Women's Health and Neuromodulation. The company markets its products to more than 25,000 hospitals, clinics, outpatient facilities and medical offices in nearly 110 countries worldwide through direct sales organizations, distributors and dealers. Its major markets include Europe, Middle East, Africa (EMEA), Japan, Asia Pacific and the Americas. Boston Scientific is headquartered in Massachusetts, the US.

The company seeks to become a global leader in less-invasive medical devices industry by developing and marketing products and therapies that cater to patient needs by extending superior clinical results and economic value.

Boston Scientific Corporation (BSX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Boston Scientific Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment Deals By Type, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Market, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deal Details
Asset Purchase
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies
Venture Financing
TVA Medical Raises USD15 Million in Series C Financing
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Channel Medsystems Raises USD22 Million in Series C Financing Round
InterVene Raises USD5.9 Million in Series A Financing
Amaranth Medical Raises Funds Through Venture Financing
Xlumena Raises US$25 Million In Series C Financing Round
Sensible Medical Raises US$20 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Channel Medsystems Raises US$9.7 Million In Series B Financing
Baronova Raises US$27.3 Million In Series C Financing
Xlumena Raises US$6 Million In Venture Financing
Neuros Medical Raises US$3.5 Million In Second Round Of Financing
NxThera Secures Additional US$9 Million In Series B Venture Financing Round
Xlumena Secures US$7 Million In Series B Financing
BridgePoint Medical Secures US$9 Million In Venture Financing
BridgePoint Medical Secures US$1 Million In Financing Round
Xlumena Raises US$3 Million In Venture Financing
TyRx Pharma Secures US$4 Million In Series D Round Of Financing
BridgePoint Medical Secures US$6.1 Million In Financing
Revascular Therapeutics Raises US$3 Million In Second Tranche Of Series B Financing
Sadra Medical Secures US$30 Million In Series C Financing
Atritech Secures US$30 Million In Series E Round Of Financing
Partnerships
BridgePoint Medical Enters Into Licensing Agreement With Covidien
ARC Enters Into Licensing Agreement With Boston Scientific
Boston Scientific Enters into Sales Cooperation Agreement with Preventice
Boston Scientific Enters into Agreement with Brainlab
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices
Terumo Medical Terminates Distribution Agreement With Boston Scientific For Glidewire
Boston Scientific Enters Into Agreement With Philips Healthcare
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers
BG Medicine Enters Into Research Collaboration With Boston Scientific
Boston Scientific Enters Into Partnership With Greatbatch Medical
Lumenis Enters Into Co-Marketing Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Fukuda Denshi
Boston Scientific Enters Into An Agreement With Philips Healthcare And Siemens Medical Solutions
Boston Scientific Enters Into Co-Marketing Agreement With Bladder Health Network
American Medical Systems Holdings Enters Into Agreement With Tissue Genesis
Pluromed Enters Into An Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Bladder Health Network
Equity Offering
Preventice Raises Funds through Private Placement of Shares
Iowa Approach Raises Funds through Private Placement of Shares
Debt Offering
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
Boston Scientific Completes Public Offering Of 4.5% Senior Notes For US$850 Million
Boston Scientific Completes Public Offering Of 6% Senior Notes For US$850 Million
Boston Scientific Completes Public Offering Of 7.38% Senior Notes For US$300 Million
Asset Transactions
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To US$5 Million
Boston Scientific Sells Neurovascular Business Unit To Stryker
CooperSurgical Acquires Her Option Global Endometrial Ablation Product Line From American Medical Systems Holdings
American Medical Systems Completes Sale Of Ovion Technology To Conceptus
Acquisition
Boston Scientific to Acquire Stake in Frankenman Medical
Boston Scientific to Acquire Xlumena for USD75 Million
Boston Scientific To Acquire Remaining 72% Stake In IoGyn
Vanguard Acquires 6.7% Stake In Boston Scientific
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to US$425 Million
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million
Endo Pharma Acquires American Medical Systems
GAMCO Investors Invest US$25 Million In American Medical Systems
Boston Scientific Completes Acquisition Of Atritech
Boston Scientific Acquires ReVascular Therapeutics
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million
Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical
Boston Scientific Acquires S.I. Therapies
Boston Scientific Completes Acquisition Of Asthmatx For Up To US$443.5 Million
Boston Scientific Acquires Labcoat
Boston Scientific Corporation - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Apr 30, 2015: Boston Scientific Collaborates With MedAxiom And TogetherMD To Bring Value Based Solutions To Healthcare Systems
Jul 02, 2014: Boston Scientific Establishes New Marlborough Headquarters
May 06, 2014: Boston Scientific joins Optum Labs as founding medical device partner
Financial Announcements
Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015
Apr 28, 2015: Boston Scientific Announces Results for First Quarter 2015
Feb 04, 2015: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2014
Oct 22, 2014: Boston Scientific Announces Results For Third Quarter Ended September 30, 2014
Jul 24, 2014: Boston Scientific Announces Results For Second Quarter Ended June 30, 2014
Apr 29, 2014: Boston Scientific Announces Results For First Quarter Ended March 31, 2014
Feb 04, 2014: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2012
Research And Development
Aug 19, 2014: Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Corporate Communications
Jul 15, 2015: Boston Scientific Elects Donna A. James To Board Of Directors
May 27, 2015: Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management
Mar 03, 2015: Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors
Mar 03, 2014: Boston Scientific Elects Edward J. Ludwig To Its Board Of Directors
Jan 06, 2014: Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology
Legal and Regulatory
May 28, 2015: Jury Finds Boston Scientific Liable For Woman's Two Defective Transvaginal Mesh Devices, Says Motley Rice
Apr 27, 2015: Transvaginal Mesh Lawsuit News: Another Joint Conference Status Meeting Ordered by Judge to Resolve More than 70K TVM Lawsuits against Several Mesh Manufacturers, Says Lawsuitsettlementnews.com
Apr 20, 2015: Transvaginal Mesh Lawsuit Settlement News Update: Legal-Bay Lawsuit Settlement Funding Announces Judge Order for another Joint Conference Status Meeting to Resolve More than 70K TVM Lawsuits
Feb 17, 2015: Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation
Oct 27, 2014: Legal-Bay Lawsuit Settlement Funding Expects More Transvaginal Mesh Lawsuit Filings after Boston Scientific Transvaginal Mesh Trial Loss
Sep 24, 2014: Maryland Court Orders Boston Scientific To Pay $308m In Damages To Mirowski Family Ventures
Aug 28, 2014: USIBC Concludes Successful Medical Device Mission to India
Aug 05, 2014: Boston Scientific Provides Update On Subpoena From U.S. Department of Health and Human Services
Feb 23, 2014: Vaginal Mesh Lawsuits Consolidated in Pennsylvania Mass Tort Proceeding, Bernstein Liebhard Reports
Government and Public Interest
Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference
Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference
Product News
Sep 10, 2015: Boston Scientific Secures CE Mark For Vercise PC Deep Brain Stimulation System
Aug 19, 2015: FDA Approves Boston Scientific’s Innova Vascular Self-expanding Stent System
Jul 20, 2015: Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology
Jun 22, 2015: Boston Scientific Begins EMBLEM Defibrillator Study In Sudden Cardiac Death
Jun 17, 2015: Newly FDA-Approved Device for Stroke Prevention Available at Mercy
Jun 04, 2015: Boston Scientific Launches The Precision Novi Spinal Cord Stimulator System in Europe
Apr 21, 2015: Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners
Apr 20, 2015: Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD System
Apr 09, 2015: Northwestern Medicine Cardiologist First in Illinois to Implant FDA-Approved WATCHMAN Heart Device
Mar 31, 2015: Boston Scientific Recalls Expel Drainage Catheter with TwistLoc Hub Biliary Drainage Catheter and BiliaryDrainage Catheter Kit
Mar 26, 2015: Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation
Mar 24, 2015: Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN Left Atrial Appendage Closure Device
Mar 18, 2015: Just Approved By FDA, New Ground Breaking Procedure for Heart Rhythm Patients
Dec 12, 2014: New Data Presented At NANS 2014 Demonstrate Long-Term, Low Back Pain Relief With Boston Scientific Precision Spectra Spinal Cord Stimulator System
Dec 10, 2014: Transvaginal Mesh Lawsuit Settlement News: Legal-Bay Lawsuit Settlement Funding Reports $18.5 Million Award for Plaintiffs in Latest Boston Scientific Mesh Trial
Nov 19, 2014: New Data From EVOLVE Clinical Program Demonstrate SYNERGY Bioabsorbable Polymer Stent Meets Key Performance Endpoints
Nov 17, 2014: First U.S. Procedures Completed With The Symphion Hysteroscopic Tissue Removal System
Nov 13, 2014: Subcutaneous Implantable Defibrillator Receives Favorable Coding And Payment Designations For 2015
Nov 03, 2014: Boston Scientific Announces Schedule For Presentations At The Upcoming North American Neuromodulation Society Meeting
Oct 20, 2014: Boston Scientific Initiates Study Of Promus PREMIER Coronary Stent System In Underserved Patient Populations
Sep 23, 2014: Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus Valve System
Sep 17, 2014: Boston Scientific Receives CE Mark For The Vercise Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
Jul 21, 2014: Boston Scientific's Rebel Coronary Stent System Gets Approval From FDA
Jul 14, 2014: Boston Scientific Gets CE Mark For New 25mm Lotus Valve System
Jul 14, 2014: Boston Scientific Receives CE Mark For Ranger Drug-Coated Balloon
Jun 11, 2014: Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise DBS System
Jun 10, 2014: Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise DBS System For Patients With Parkinson's Disease
Jun 04, 2014: Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus Valve System
May 21, 2014: Boston Scientific Reports Strong Performance Data For SYNERGY Stent System
May 08, 2014: New Data Presented At WIP 2014 Demonstrate Sustained Low Back Pain Relief With The Boston Scientific Precision Spectra Spinal Cord Stimulator System
May 01, 2014: Boston Scientific Launches Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan
Apr 22, 2014: Boston Scientific Begins Clinical Trial of ACUITY X4 LV Pacing Leads
Apr 22, 2014: Boston Scientific Begins Clinical Trial of RELIANCE 4-FRONT ICD Leads
Apr 15, 2014: Preliminary Injunction Against Boston Scientific's Guidezilla Catheter Vacated by Federal Circuit
Apr 10, 2014: First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinson's Disease
Apr 07, 2014: Boston Scientific Begins Expansion of The S-ICD System in Asia
Apr 07, 2014: Boston Scientific Introduces the Expect Slimline Needle for Use During Endoscopic Ultrasound Fine Needle Aspiration Procedures
Apr 01, 2014: New Data Illustrate Long-Term Safety And Effectiveness Of The Boston Scientific S-ICD System
Apr 01, 2014: Washington Hospital Physician Among the First in Bay Area to Implant Lifesaving Device for Patients at Risk of Sudden Cardiac Death
Mar 14, 2014: Boston Scientific Announces CE Mark Approval and First Implants of Ingevity MRI Pacing Leads
Mar 12, 2014: Boston Scientific Receives CE Mark Approval for REBEL Platinum Chromium Coronary Stent System
Mar 12, 2014: Boston Scientific’s REBEL Platinum Chromium Coronary Stent System Gets CE Mark Approval
Feb 14, 2014: Boston Scientific’s Fully Covered Esophageal Metal Stent Gets CE Mark
Feb 05, 2014: Boston Scientific Introduces OffRoad Re-entry Catheter System In US
Jan 13, 2014: Preliminary Injunction Against Boston Scientific's Guidezilla Catheter Becomes Effective
Jan 08, 2014: Florida hospital offers Boston Scientific's implantable defibrillator for at-risk heart patients
Product Approvals
Sep 10, 2015: Boston Scientific Secures CE Mark For Vercise PC Deep Brain Stimulation System
Aug 19, 2015: FDA Approves Boston Scientific’s Innova Vascular Self-expanding Stent System
Sep 17, 2014: Boston Scientific Receives CE Mark For The Vercise Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
Jul 21, 2014: Boston Scientific's Rebel Coronary Stent System Gets Approval From FDA
Jul 14, 2014: Boston Scientific Gets CE Mark For New 25mm Lotus Valve System
Jul 14, 2014: Boston Scientific Receives CE Mark For Ranger Drug-Coated Balloon
Mar 14, 2014: Boston Scientific Announces CE Mark Approval and First Implants of Ingevity MRI Pacing Leads
Mar 12, 2014: Boston Scientific’s REBEL Platinum Chromium Coronary Stent System Gets CE Mark Approval
Feb 14, 2014: Boston Scientific’s Fully Covered Esophageal Metal Stent Gets CE Mark
Clinical Trials
Jul 20, 2015: Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology
Jun 22, 2015: Boston Scientific Begins EMBLEM Defibrillator Study In Sudden Cardiac Death
Apr 20, 2015: Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD System
Nov 19, 2014: New Data From EVOLVE Clinical Program Demonstrate SYNERGY Bioabsorbable Polymer Stent Meets Key Performance Endpoints
Oct 20, 2014: Boston Scientific Initiates Study Of Promus PREMIER Coronary Stent System In Underserved Patient Populations
Sep 23, 2014: Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus Valve System
Jun 11, 2014: Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise DBS System
Jun 10, 2014: Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise DBS System For Patients With Parkinson's Disease
Jun 04, 2014: Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus Valve System
Apr 22, 2014: Boston Scientific Begins Clinical Trial of ACUITY X4 LV Pacing Leads
Apr 22, 2014: Boston Scientific Begins Clinical Trial of RELIANCE 4-FRONT ICD Leads
Apr 10, 2014: First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinson's Disease
Other Significant Developments
May 06, 2015: Boston Scientific Coyol, Costa Rica Facility Earns Shingo Award For Excellence In Manufacturing
May 01, 2015: Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day
Feb 03, 2015: Boston Scientific Maple Grove Operations Named A 2014 'Best Plants' Winner
Mar 19, 2014: Boston Scientific Receives Prestigious Shingo Award for Operational Excellence
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Boston Scientific Corporation, Medical Equipment, Key Facts, 2014
Boston Scientific Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment Deals By Type, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Boston Scientific Corporation, Deals By Market, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies
TVA Medical Raises USD15 Million in Series C Financing
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Channel Medsystems Raises USD22 Million in Series C Financing Round
InterVene Raises USD5.9 Million in Series A Financing
Amaranth Medical Raises Funds Through Venture Financing
Xlumena Raises US$25 Million In Series C Financing Round
Sensible Medical Raises US$20 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Channel Medsystems Raises US$9.7 Million In Series B Financing
Baronova Raises US$27.3 Million In Series C Financing
Xlumena Raises US$6 Million In Venture Financing
Neuros Medical Raises US$3.5 Million In Second Round Of Financing
NxThera Secures Additional US$9 Million In Series B Venture Financing Round
Xlumena Secures US$7 Million In Series B Financing
BridgePoint Medical Secures US$9 Million In Venture Financing
BridgePoint Medical Secures US$1 Million In Financing Round
Xlumena Raises US$3 Million In Venture Financing
TyRx Pharma Secures US$4 Million In Series D Round Of Financing
BridgePoint Medical Secures US$6.1 Million In Financing
Revascular Therapeutics Raises US$3 Million In Second Tranche Of Series B Financing
Sadra Medical Secures US$30 Million In Series C Financing
Atritech Secures US$30 Million In Series E Round Of Financing
BridgePoint Medical Enters Into Licensing Agreement With Covidien
ARC Enters Into Licensing Agreement With Boston Scientific
Boston Scientific Enters into Sales Cooperation Agreement with Preventice
Boston Scientific Enters into Agreement with Brainlab
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices
Terumo Medical Terminates Distribution Agreement With Boston Scientific For Glidewire
Boston Scientific Enters Into Agreement With Philips Healthcare
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers
BG Medicine Enters Into Research Collaboration With Boston Scientific
Boston Scientific Enters Into Partnership With Greatbatch Medical
Lumenis Enters Into Co-Marketing Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Fukuda Denshi
Boston Scientific Enters Into An Agreement With Philips Healthcare And Siemens Medical Solutions
Boston Scientific Enters Into Co-Marketing Agreement With Bladder Health Network
American Medical Systems Holdings Enters Into Agreement With Tissue Genesis
Pluromed Enters Into An Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Bladder Health Network
Preventice Raises Funds through Private Placement of Shares
Iowa Approach Raises Funds through Private Placement of Shares
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
Boston Scientific Completes Public Offering Of 4.5% Senior Notes For US$850 Million
Boston Scientific Completes Public Offering Of 6% Senior Notes For US$850 Million
Boston Scientific Completes Public Offering Of 7.38% Senior Notes For US$300 Million
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To US$5 Million
Boston Scientific Sells Neurovascular Business Unit To Stryker
CooperSurgical Acquires Her Option Global Endometrial Ablation Product Line From American Medical Systems Holdings
American Medical Systems Completes Sale Of Ovion Technology To Conceptus
Boston Scientific to Acquire Stake in Frankenman Medical
Boston Scientific to Acquire Xlumena for USD75 Million
Boston Scientific To Acquire Remaining 72% Stake In IoGyn
Vanguard Acquires 6.7% Stake In Boston Scientific
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to US$425 Million
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million
Endo Pharma Acquires American Medical Systems
GAMCO Investors Invest US$25 Million In American Medical Systems
Boston Scientific Completes Acquisition Of Atritech
Boston Scientific Acquires ReVascular Therapeutics
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million
Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical
Boston Scientific Acquires S.I. Therapies
Boston Scientific Completes Acquisition Of Asthmatx For Up To US$443.5 Million
Boston Scientific Acquires Labcoat
Boston Scientific Corporation, Key Competitors
Boston Scientific Corporation, Key Employees
Boston Scientific Corporation, Other Locations
Boston Scientific Corporation, Subsidiaries

LIST OF FIGURES

Boston Scientific Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Market, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Boston Scientific Corporation, Medical Equipment, Deals by Market, 2009 to YTD 2015
Skip to top


Ask Your Question

Boston Scientific Corporation (BSX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: